Cargando…
Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines
BACKGROUND: Risk-stratified treatment recommendations facilitate treatment decision-making that balances patient-specific risks and preferences. It is unclear if and how such recommendations are developed in clinical practice guidelines (CPGs). Our aim was to assess if and how CPGs develop risk-stra...
Autores principales: | Yu, Tsung, Vollenweider, Daniela, Varadhan, Ravi, Li, Tianjing, Boyd, Cynthia, Puhan, Milo A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565912/ https://www.ncbi.nlm.nih.gov/pubmed/23302096 http://dx.doi.org/10.1186/1741-7015-11-7 |
Ejemplares similares
-
Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
por: Puhan, Milo A., et al.
Publicado: (2015) -
High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease
por: Vollenweider, Daniela, et al.
Publicado: (2011) -
Informing Evidence-Based Decision-Making for Patients with Comorbidity: Availability of Necessary Information in Clinical Trials for Chronic Diseases
por: Boyd, Cynthia M., et al.
Publicado: (2012) -
A framework for organizing and selecting quantitative approaches for benefit-harm assessment
por: Puhan, Milo A, et al.
Publicado: (2012) -
Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review
por: Puhan, Milo A, et al.
Publicado: (2008)